DGAP-News: Novavax to Present at the Jefferies 2014 Global Healthcare Conference

        Print
| Source: EQS Group AG
DGAP-News: Novavax, Inc. /
Novavax to Present at the Jefferies 2014 Global Healthcare Conference

02.06.2014 / 23:55

---------------------------------------------------------------------

GAITHERSBURG, Md., 2014-06-02 23:55 CEST (GLOBE NEWSWIRE) --
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today
that Stanley C. Erck, President and Chief Executive Officer, will present at
the following event: 

Event:    Jefferies 2014 Global Healthcare Conference    
Date:     June 5, 2014                                   
Time:     9:00 am ET                                     
Webcast:  www.novavax.com, via 'Investor Info/Events' tab

A replay of the conference call will be available from 9:30 am on June 5, 2014
until midnight September 5, 2014 and can be found on the 'Investor Info/Events'
tab on the Novavax website. 

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company
creating novel vaccines and vaccine adjuvants to address a broad range of
infectious diseases worldwide. Using innovative proprietary recombinant protein
nanoparticle vaccine technology, the company produces vaccine candidates to
efficiently and effectively respond to both known and newly emergent diseases.
Additional information about Novavax is available on the company's website,
novavax.com. 


         CONTACT: Barclay A. Phillips
         SVP, Chief Financial Officer and Treasurer
         Novavax, Inc.
         240-268-2000
News Source: NASDAQ OMX


End of Corporate News

---------------------------------------------------------------------

02.06.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English        
Company:     Novavax, Inc.  
 
 
             United States  
ISIN:        US6700021040   
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
271808 02.06.2014